Aberrant signaling due to gain of function mutations in the IL-7Rα gene has been shown to promote the survival of T-cell ALL (T-ALL), especially when associated with cytokine receptor-like factor 2 (CRLF2), another gene mutation associated with pediatric ALL [74,75]. This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.